Are Patients and Their Providers Talking About Long-Acting Injectable Antiretroviral Therapy? Penetration into Clinical Encounters at Three U.S. Care Sites. (11th June 2022)

• Record Type: Journal Article
• Authors: Christopoulos, Katerina A; Colasanti, Jonathan; Johnson, Mallory O; Diaz Tsuzuki, Manami; Erguera, Xavier A; Flores, Rey; Kerman, Jared; Dance, Kaylin; Sauceda, John A; Neilands, Torsten B; Dilworth, Samantha E; Koester, Kimberly A; Gutierrez, Jose; Schneider, John A; Montgomery, Elizabeth; McNulty, Moira C
• Is Part Of: Open forum infectious diseases. Volume 9:Number 7(2022)
• Publication Date: 2022-06-11
• Subjects: long-acting injectable antiretroviral therapy -- implementation science; Communicable diseases -- Periodicals; Medical microbiology -- Periodicals; Infection -- Periodicals; 616.9
• DOI: 10.1093/ofid/ofac293
• Languages: English
• ISSNs: 2328-8957

Abstract

Abstract: Use of long-acting injectable antiretroviral therapy depends on patient awareness, provider discussion, and patient willingness to use. We conducted a postvisit survey with patients at 3 HIV clinics in San Francisco, Chicago, and Atlanta in May 2021 to assess for inequities in these early implementation phases.